Effect of Eriodictyol on Collagen-Induced Arthritis in Rats by Akt/HIF-1α Pathway

References

• FranzJK, KolbSA, HummelKM, et al. Interleukin-16, produced by synovial fibroblasts, mediates chemoattraction for CD4+ T lymphocytes in rheumatoid arthritis. Eur J Immunol. 1998;28(9):2661–2671. doi:10.1002/(SICI)1521-4141(199809)28:09<2661::AID-IMMU2661>3.0.CO;2-N9754554
   PubMed Web of Science ®Google Scholar
• CicciaF, GugginoG, RizzoA, et al. Potential involvement of IL-9 and Th9 cells in the pathogenesis of rheumatoid arthritis. Rheumatology. 2015;54(12):2264. doi:10.1093/rheumatology/kev25226178600
   PubMed Web of Science ®Google Scholar
• AnY, LiuT, HeD, et al. The usage of biological DMARDs and clinical remission of rheumatoid arthritis in China: a real-world large scale study. Clin Rheumatol. 2017;36(1):35–43. doi:10.1007/s10067-016-3424-527709444
   PubMed Web of Science ®Google Scholar
• MulherinD, FitzgeraldO, BresnihanB. Synovial tissue macrophage population and articular damage in rheumatoid arthritis. Arthritis Rheum. 1996;39(1):115–124. doi:10.1002/art.17803901168546720
   PubMed Web of Science ®Google Scholar
• AndreasK, HäuplT, LübkeC, et al. Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15. doi:10.1186/ar260519192274
   PubMed Web of Science ®Google Scholar
• BernatskyS, HudsonM, SuissaS. Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis. Rheumatology. 2007;46(7):1157–1160. doi:10.1093/rheumatology/kem07617478469
   PubMed Web of Science ®Google Scholar
• DengGM, LenardoM. The role of immune cells and cytokines in the pathogenesis of rheumatoid arthritis. Drug Discov Today Dis Mech. 2006;3(2):163–168. doi:10.1016/j.ddmec.2006.06.009
   Google Scholar
• LiuK, Cho-Y-Y, YaoK, et al. Eriodictyol Inhibits RSK2-ATF1 signaling and suppresses EGF-induced neoplastic cell transformation. J Biol Chem. 2011;286(3):2057–2066. doi:10.1074/jbc.M110.14730621098035
   PubMed Web of Science ®Google Scholar
• LeeER, KimJH, KangYJ, ChoSG. The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes. Biol Pharm Bull. 2007;30(1):32–37. doi:10.1248/bpb.30.3217202655
   PubMed Web of Science ®Google Scholar
• Mokdad-BzeouichI, MustaphaN, SassiA, et al. Investigation of immunomodulatory and anti-inflammatory effects of eriodictyol through its cellular anti-oxidant activity. Cell Stress Chaperones. 2016;21(5):773–781. doi:10.1007/s12192-016-0702-827250501
   PubMed Web of Science ®Google Scholar
• BucoloC, LeggioGM, DragoF, SalomoneS. Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats. Biochem Pharmacol. 2012;84(1):88–92.doi:10.1016/j.bcp.2012.03.01922484312
   PubMed Web of Science ®Google Scholar
• LeeSE, ParkHR, YunHD, et al. Integrated miRNA and mRNA expression profiling in response to eriodictyol in human endothelial cells. Biochip J. 2017;11(3):188–195. doi:10.1007/s13206-017-1303-z
   Web of Science ®Google Scholar
• GibofskyA. Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care. 2012;18(13 Suppl):295–302.
   PubMedGoogle Scholar
• CheminK, KlareskogL, MalmströmV. Is rheumatoid arthritis an autoimmune disease? Curr Opin Rheumatol. 2016;28(2):1. doi:10.1097/BOR.0000000000000253
   Web of Science ®Google Scholar
• DewedarAM, ShalabyMA, Al‐HomaidS, MahfouzAM, ShamsOA, FathyA. Lack of adverse effect of anti-tumor necrosis factor-α biologics in treatment of rheumatoid arthritis: 5? Years follow-up. Int J Rheum Dis. 2012;15(3):330–335. doi:10.1111/j.1756-185X.2012.01715.x22709496
   PubMed Web of Science ®Google Scholar
• JiangM, ZhaQ, HeY, LuA. Risk factors of gastrointestinal and hepatic adverse drug reactions in the treatment of rheumatoid arthritis with biomedical combination therapy and Chinese medicine. J Ethnopharmacol. 2012;141(2):615–621. doi:10.1016/j.jep.2011.07.02621782923
   PubMed Web of Science ®Google Scholar
• SantosaA, NgPSL, TengGG. Traditional Chinese medication for rheumatoid arthritis: more than what meets the eye. Rheumatol Int. 2015;35(2):383–384. doi:10.1007/s00296-014-3092-125037898
   PubMed Web of Science ®Google Scholar
• LuC, XiaoC, ChenG, et al. Cold and heat pattern of rheumatoid arthritis in traditional Chinese medicine: distinct molecular signatures identified by microarray expression profiles in CD4-positive T cell. Rheumatol Int. 2012;32(1):61–68. doi:10.1007/s00296-010-1546-720658292
   PubMed Web of Science ®Google Scholar
• QuY, ZhangYP, WuJ, et al. Downregulated microRNA‐135a ameliorates rheumatoid arthritis by inactivation of the phosphatidylinositol 3‐kinase/AKT signaling pathway via phosphatidylinositol 3‐kinase regulatory subunit 2. J Cell Physiol. 2019;234(10):17663–17676. doi:10.1002/jcp.2839030912120
   PubMed Web of Science ®Google Scholar
• YothaisongS, ThaneeM, NamwatN, YongvanitP, LoilomeW. Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model. Asian Pac J Cancer Prev. 2014;15(23):10463–10468. doi:10.7314/APJCP.2014.15.23.1046325556493
   PubMedGoogle Scholar
• NadkarniS, MauriC, EhrensteinMR. Anti-TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β J Exp Med. 2007;204(1):33–39. doi:10.1084/jem.20061531.17200409
   PubMed Web of Science ®Google Scholar
• GerlagDM, HaringmanJJ, SmeetsTJM, et al. Effects of oral prednisolone on biomarkers in synovial tissue and clinical improvement in rheumatoid arthritis. Arthritis Rheum. 2004;50(12):3783–3791. doi:10.1002/art.2066415593225
   PubMed Web of Science ®Google Scholar
• GuoW, LiuCF, LinN. Synovial angiogenesis in rheumatoid arthritis and intervention of traditional Chinese medicine. Chin J Exp Traditional Med Formulae. 2012;10: 308-312. doi:10.13422/j.cnki.syfjx.2012.10.016
   Google Scholar
• BabaogluH. Abnormal retinal microvasculature found in active rheumatoid arthritis: a different perspective of microvascular health. Turk J Med Sci. 2019;49(1):20–26. doi:10.3906/sag-1806-130761837
   PubMed Web of Science ®Google Scholar
• ScharteM, HanX, UchiyamaT, TawadrousZ, DeludeRL, FinkMP. LPS increases hepatic HIF-1α protein and expression of the HIF-1-dependent gene aldolase A in rats. J Surg Res 2006;135(2):262–267. doi:10.1016/j.jss.2006.05.02716930621
   PubMed Web of Science ®Google Scholar
• ChenT, MouY, TanJ, et al. The protective effect of CDDO-Me on lipopolysaccharide-induced acute lung injury in mice. Int Immunopharmacol. 2015;25:55–64. doi:10.1016/j.intimp.2015.01.01125614226
   PubMed Web of Science ®Google Scholar
• NewtonRC, DeciccoCP. Therapeutic potential and strategies for inhibiting tumor necrosis factor-α. J Med Chem. 1999;42:2295–2314. doi:10.1021/jm980541n10395470
   PubMed Web of Science ®Google Scholar